• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过程序控制行为评估麻醉激动剂、部分激动剂和拮抗剂之间的相互作用。

Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

作者信息

Harris R A

出版信息

J Pharmacol Exp Ther. 1980 Jun;213(3):497-503.

PMID:6110766
Abstract

The effects of morphine, butorphanol, cyclazocine, ketocyclazocine, ethylketocyclazocine, and SKF-10,047 were tested, alone and in conjunction with naloxone or naltrexone, in rats responding under a fixed-interval, 5-min schedule of food presentation. Except for naloxone and naltrexone, all of the drugs decreased the average rate of responding in a dose-dependent manner. The rate-decreasing effects of morphine were markedly antagonized by naltrexone, while the effects of SKF-10,047 or high doses of cyclazocine were not antagonized by naltrexone or naloxone. Naltrexone and naloxone were able to antagonize the effects of butorphanol, ketocyclazocine, ethylketocyclazocine and low doses of cyclazocine, but these drugs were considerably more difficult to antagonize than was morphine. Thus, the interactions between these drugs and the narcotic antagonists allow the classification of the drugs into three groups, based on a marked shift, a moderate shift or no shift in the dose-response curve. This classification is consistent with the hypothesis of Martin et al., (Journal of Pharmacology and Experimental Therapeutics, 197: 517-532, 1976) regarding distinct receptors for morphine and related drugs (mu agonists), ketocyclazocine and ethylketocyclazocine (kappa agonists) and SKF-10,047 (sigma agonist).

摘要

在以固定间隔5分钟呈现食物的实验安排下,对大鼠测试了吗啡、布托啡诺、环唑辛、酮环唑辛、乙基酮环唑辛和SKF - 10,047单独使用以及与纳洛酮或纳曲酮联合使用时的效果。除纳洛酮和纳曲酮外,所有药物均以剂量依赖的方式降低了平均反应率。纳曲酮显著拮抗了吗啡的反应率降低作用,而纳曲酮或纳洛酮并未拮抗SKF - 10,047或高剂量环唑辛的作用。纳曲酮和纳洛酮能够拮抗布托啡诺、酮环唑辛、乙基酮环唑辛和低剂量环唑辛的作用,但这些药物比吗啡更难被拮抗。因此,根据剂量 - 反应曲线的显著偏移、适度偏移或无偏移,这些药物与麻醉拮抗剂之间的相互作用可将药物分为三组。这种分类与Martin等人(《药理学与实验治疗学杂志》,197: 517 - 532, 1976)关于吗啡及相关药物(μ激动剂)、酮环唑辛和乙基酮环唑辛(κ激动剂)以及SKF - 10,047(σ激动剂)的不同受体的假设一致。

相似文献

1
Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.通过程序控制行为评估麻醉激动剂、部分激动剂和拮抗剂之间的相互作用。
J Pharmacol Exp Ther. 1980 Jun;213(3):497-503.
2
Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.通过对大鼠受罚和未受罚行为的评估来研究麻醉性激动剂、部分激动剂和拮抗剂之间的相互作用。
Psychopharmacology (Berl). 1982;76(2):177-81. doi: 10.1007/BF00435274.
3
Place-conditioning properties of mu, kappa, and sigma opioid agonists.μ、κ和σ阿片样物质激动剂的位置条件反射特性。
Alcohol Drug Res. 1985;6(5):327-39.
4
Limitations on the antagonistic actions of opioid antagonists.阿片类拮抗剂拮抗作用的局限性。
Fed Proc. 1982 May;41(7):2333-8.
5
Meperidine effects on schedule-controlled responding.哌替啶对按时间表控制的反应的影响。
J Pharmacol Exp Ther. 1977 May;201(2):434-43.
6
Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.纳曲酮对阿片类药物影响大鼠固定比率辨别力的差异拮抗作用。
J Pharmacol Exp Ther. 1988 Jan;244(1):237-46.
7
Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.急性阿片类药物预处理诱导大鼠对纳曲酮降低心率作用致敏的药理学特征
J Pharmacol Exp Ther. 1990 May;253(2):483-9.
8
Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.阿片类激动剂对吗啡依赖鸽子的辨别性刺激作用。
J Pharmacol Exp Ther. 1990 Aug;254(2):626-32.
9
Blocking of enhanced sensitivity to behavioral effects of naloxone induced by narcotic agonists in rats.对麻醉激动剂诱导的大鼠对纳洛酮行为效应增强敏感性的阻断作用。
Indian J Physiol Pharmacol. 2003 Oct;47(4):407-14.
10
Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.阿片类拮抗剂对鸽子的拮抗作用和心率抑制作用。
J Pharmacol Exp Ther. 1985 Nov;235(2):442-7.

引用本文的文献

1
The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.东革阿里碱和吗啡对大鼠条件性位置偏爱和镇痛反应的影响。
Psychopharmacology (Berl). 2019 Sep;236(9):2725-2734. doi: 10.1007/s00213-019-05247-7. Epub 2019 May 17.
2
WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.WIN 44,441:一种立体专一性长效阿片受体拮抗剂。
Pharm Res. 1984 Jan;1(1):46-8. doi: 10.1023/A:1016386811268.
3
Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.
κ阿片受体介导的新物体识别障碍:与精神兴奋剂治疗的相关性。
J Addict Res Ther. 2011;S4. doi: 10.4172/2155-6105.S4-007. Epub 2011 Dec 24.
4
Interactions between morphine, scopolamine and nicotine: schedule-controlled responding in rats.吗啡、东莨菪碱和尼古丁之间的相互作用:大鼠的时间表控制反应。
Pharmacol Biochem Behav. 2010 Jul;96(1):91-5. doi: 10.1016/j.pbb.2010.04.011. Epub 2010 Apr 24.
5
Increased food and water intake produced in rats by opiate receptor agonists.阿片受体激动剂使大鼠的食物和水摄入量增加。
Psychopharmacology (Berl). 1981;74(3):217-20. doi: 10.1007/BF00427097.
6
Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.苯环利定、氟哌啶醇和纳洛酮对大鼠固定间隔行为表现的影响。
Psychopharmacology (Berl). 1984;84(1):32-8. doi: 10.1007/BF00432020.
7
Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.通过对大鼠受罚和未受罚行为的评估来研究麻醉性激动剂、部分激动剂和拮抗剂之间的相互作用。
Psychopharmacology (Berl). 1982;76(2):177-81. doi: 10.1007/BF00435274.
8
Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques.猕猴中乙基酮唑辛、环唑辛和烯丙吗啡辨别效应的拮抗作用。
Psychopharmacology (Berl). 1984;84(3):356-61. doi: 10.1007/BF00555213.
9
Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.纳洛酮增强右美沙芬对大鼠固定间隔行为表现的破坏作用。
Psychopharmacology (Berl). 1986;90(3):408-11. doi: 10.1007/BF00179200.
10
Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone.急性吗啡预处理对纳洛酮降低速率及拮抗活性的影响。
Psychopharmacology (Berl). 1986;88(2):201-8. doi: 10.1007/BF00652241.